FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/068843 [Registered on: 13/06/2024] Trial Registered Prospectively
Last Modified On: 11/06/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Assessing the effect of Kankola in hypertension  
Scientific Title of Study   Pharmaco-therapeutic effect of Kankola (Piper cubeba Linn.f.)Phala in the management of Uchcha-raktchap (Hypertension) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Prachi Goyal 
Designation  MD SCHOLAR 
Affiliation  Post Graduate Institute of Ayurveda DSRRAU Jodhpur 
Address  Department of Dravyaguna Post Graduate institute of Ayurveda DSSRAU Naguar road karwar Jodhpur

Jodhpur
RAJASTHAN
342037
India 
Phone  9460754660  
Fax    
Email  gprachigoyal929@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Prachi Goyal 
Designation  MD SCHOLAR 
Affiliation  Post Graduate Institute of Ayurveda DSRRAU Jodhpur 
Address  Department of Dravyaguna Post Graduate institute of Ayurveda DSSRAU Naguar road karwar Jodhpur

Jodhpur
RAJASTHAN
342037
India 
Phone  9460754660  
Fax    
Email  gprachigoyal929@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Rajendra Prasad Purvia 
Designation  Associate Professor  
Affiliation  Post Graduate Institute of Ayurveda DSRRAU Jodhpur 
Address  Department of Dravyaguna Post graduate institute of Ayurveda DSSRAUNaguar road karwar Jodhpur

Jodhpur
RAJASTHAN
342037
India 
Phone  9782230577  
Fax    
Email  drrajpurvia@gmail.com  
 
Source of Monetary or Material Support  
Post Graduate institute of Ayurveda , DSSRAU , naguar road Karwar jodhpur rajasthan india 342037 
 
Primary Sponsor  
Name  Post Graduate institute of Ayurveda , DSSRAU JODHPUR 
Address  Department of Dravyaguna , Post Graduate institute of Ayurveda , DSSRAU JODHPUR naguar road Karwar, Rajasthan 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr RAJENDRA PRASAD PURVIA  Sanjeevani Hospital   Department of Dravyaguna ,Post Graduate institute of Ayurveda , DSSRAU, Naguar road , Karwar , Jodhpur
Jodhpur
RAJASTHAN 
9782230577

drrajpurvia@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Dr. Sarvepalli Radhkrishnan Ayurved University Post Graduate institute of Ayurved Institutional Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:I10||Essential (primary) hypertension. Ayurveda Condition: RAKTAVRUTAVATAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Kankola, Reference: Kaidev Nighantu, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 2 Months, anupAna/sahapAna: Yes(details: -Lukewarm water), Additional Information: -
 
Inclusion Criteria  
Age From  35.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Age group 35- 60 years of age.
2. Patient having symptoms of continuous raised blood pressure.
3.Patient having Systolic blood pressure between 140 to 160mm of Hg and Diastolic blood pressure between 90-100mm of Hg. 
 
ExclusionCriteria 
Details  1. Age less than 35 years and more than 60 years of age.
2. Patients having Systolic blood pressure ≤140 and ≥160 mm of Hg and Diastolic blood pressure ≤90
and ≥100mm of Hg.
3. Pregnant women and lactating mother.
4. Patients receiving on anti hypertensive drug.
5. Complicated hypertensive cases e.g. Nephropathy and left ventricular hypertrophy, heart block ,
congestive heart failure, coronary artery disease and retinopathy. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Changes in blood pressure will be assessed.   60 days 
 
Secondary Outcome  
Outcome  TimePoints 
Changes in
1. RFT/KFT
2. CBC
3. Lipid Profile ( HDL, LDL, VLDL, TG)
4. ECG
 
60 days 
 
Target Sample Size   Total Sample Size="45"
Sample Size from India="45" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   01/07/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is an interventional open label single arm trial to evaluate the efficacy of Kankola (Piper cubeba linn) in management of Hypertension . In this study 3gms of Kankola Phala Churna will be given to patients thrice a day with lukewarm water for 60 days.  the treatment period will be of 60 days. The follow up period will of 30 days during the trial and 30 days after completion of the trial.  
Close